Clinical Trial Update: Safety and Efficacy of VDPHL01 in Males and Females With AGA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the safety and efficacy of VDPHL01 for androgenetic alopecia in adult males and females; the study is currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• VDPHL01

Snippet

Sponsor: Veradermics, Inc. | Conditions: Androgenetic Alopecia, AGA | Phase 2 | Status: ACTIVE_NOT_RECRUITING